Drugplain

Hetlioz LQ 4 mg/mL

tasimelteon · SUSPENSION · Vanda Pharmaceuticals Inc.

No Recall History
Plain English

Hetlioz LQ is a suspension containing tasimelteon at 4 mg/mL, taken oral. Manufactured by Vanda Pharmaceuticals Inc..

Key Facts

Brand Name
Hetlioz LQ
Generic Name
tasimelteon
NDC Code (Product)
43068-304
Manufacturer
Vanda Pharmaceuticals Inc.
Strength
4 mg/mL
Dosage Form
SUSPENSION
Route
ORAL
Marketing Status
Application #
NDA214517
Drug Class
Melatonin Receptor Agonist [EPC]
Marketing Start
12/10/2020

Recall History

No Recall History

Frequently Asked Questions

What is Hetlioz LQ used for?

Hetlioz LQ contains tasimelteon. It is a suspension taken oral. Consult your doctor for specific uses.

Is Hetlioz LQ a controlled substance?

Hetlioz LQ is not classified as a controlled substance by the DEA.

What is the generic name for Hetlioz LQ?

The generic name for Hetlioz LQ is tasimelteon. There are 4 other brand versions of tasimelteon.

What is the NDC code for Hetlioz LQ 4 mg/mL?

The NDC (National Drug Code) for Hetlioz LQ 4 mg/mL is 43068-304, listed by Vanda Pharmaceuticals Inc..

Product NDC

43068-304

Package NDC

43068-304-02

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)